Literature DB >> 33721214

Gabapentinoids for Pruritus in Older Adults: A Narrative Review.

Shreya A Sreekantaswamy1,2, Nicholas Mollanazar3, Daniel C Butler4.   

Abstract

There is currently no standardized algorithm for the treatment of chronic pruritus (CP), or itch lasting more than 6 weeks, in adults aged ≥ 65 years. The antiepileptic agents gabapentin and pregabalin, however, are gaining popularity in the dermatologic community for their efficacy in treating CP of neuropathic origin. Yet the lack of literature specifically looking at the safety and efficacy of these medications in older adults results in limited guidance for providers in the safe use of gabapentinoids. In this paper we discuss special considerations and recommendations for treating older adults with gabapentin and pregabalin and explore the possibility for these drugs to ameliorate CP of multiple etiologies.

Entities:  

Keywords:  Chronic pruritus; Gabapentin; Gabapentinoid; Itch; Older adult; Pregabalin

Year:  2021        PMID: 33721214     DOI: 10.1007/s13555-021-00513-z

Source DB:  PubMed          Journal:  Dermatol Ther (Heidelb)


  39 in total

1.  European S2k Guideline on Chronic Pruritus.

Authors:  Elke Weisshaar; Jacek C Szepietowski; Florence J Dalgard; Simone Garcovich; Uwe Gieler; Ana M Giménez-Arnau; Julien Lambert; Tabi Leslie; Thomas Mettang; Laurent Misery; Ekin Şavk; Markus Streit; Erwin Tschachler; Joanna Wallengren; Sonja Ständer
Journal:  Acta Derm Venereol       Date:  2019-04-01       Impact factor: 4.437

Review 2.  Itch: From mechanism to (novel) therapeutic approaches.

Authors:  Gil Yosipovitch; Jordan Daniel Rosen; Takashi Hashimoto
Journal:  J Allergy Clin Immunol       Date:  2018-11       Impact factor: 10.793

3.  Use of Systemic Treatment in Patients with Chronic Pruritus: A Survey of Dermatologists in the Netherlands.

Authors:  Tessa A Kouwenhoven; Peter C M van de Kerkhof; Marijke Kamsteeg
Journal:  Acta Derm Venereol       Date:  2019-03-01       Impact factor: 4.437

Review 4.  Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery.

Authors:  Charles P Taylor; Timothy Angelotti; Eric Fauman
Journal:  Epilepsy Res       Date:  2006-11-28       Impact factor: 3.045

Review 5.  Pruritus in the older patient: a clinical review.

Authors:  Timothy G Berger; Melissa Shive; G Michael Harper
Journal:  JAMA       Date:  2013-12-11       Impact factor: 56.272

Review 6.  Gabapentin and pregabalin for the treatment of chronic pruritus.

Authors:  Kazuki M Matsuda; Divya Sharma; Ariel R Schonfeld; Shawn G Kwatra
Journal:  J Am Acad Dermatol       Date:  2016-05-17       Impact factor: 11.527

7.  Clinical classification of itch: a position paper of the International Forum for the Study of Itch.

Authors:  Sonja Ständer; Elke Weisshaar; Thomas Mettang; Jacek C Szepietowski; Earl Carstens; Akihiko Ikoma; Nora V Bergasa; Uwe Gieler; Laurent Misery; Joanna Wallengren; Ulf Darsow; Markus Streit; Dieter Metze; Thomas A Luger; Malcolm W Greaves; Martin Schmelz; Gil Yosipovitch; Jeffrey D Bernhard
Journal:  Acta Derm Venereol       Date:  2007       Impact factor: 4.437

8.  Neuropathic itch: diagnosis and management.

Authors:  Astrid Stumpf; Sonja Ständer
Journal:  Dermatol Ther       Date:  2013 Mar-Apr       Impact factor: 2.851

Review 9.  Epidemiology of itch: adding to the burden of skin morbidity.

Authors:  Elke Weisshaar; Florence Dalgard
Journal:  Acta Derm Venereol       Date:  2009       Impact factor: 4.437

Review 10.  Chronic pruritus in the elderly: pathophysiology, diagnosis and management.

Authors:  Rodrigo Valdes-Rodriguez; Carolyn Stull; Gil Yosipovitch
Journal:  Drugs Aging       Date:  2015-03       Impact factor: 4.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.